ICCO logo

InterCare DX, Inc. (ICCO) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören InterCare DX, Inc. (ICCO), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 17 Mar 2026
47/100 AI Puanı

InterCare DX, Inc. (ICCO) Sağlık ve Boru Hattı Genel Bakışı

MerkezHawthorne, United States
SektörHealthcare

InterCare DX, Inc. specializes in biomedical software development, offering solutions for relaxation, stress management, and healthcare integration. Its integrated platforms target diverse sectors, including education and hospitality, positioning it as a versatile player in health information services with a focus on software-driven solutions.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

InterCare DX, Inc. presents a focused approach to biomedical software development, targeting niche areas within healthcare and education. The company's integrated software solutions, such as the e-Learning Integrated Technology Enterprise Systems and InterCare Clinical Explorer, aim to streamline operations and enhance patient care. However, with a market capitalization of $0.00B and negative free cash flow of $-0.00B, the company's financial performance warrants careful consideration. A beta of -1.67 suggests an inverse correlation to market movements, which could be seen as a defensive characteristic. Key value drivers include the potential for increased adoption of its software solutions in the healthcare and education sectors. Upcoming growth catalysts may include new product launches or strategic partnerships. Potential risks include competition from larger, more established players and the need for continuous innovation to maintain market relevance. Investors should closely monitor the company's ability to generate revenue and achieve profitability.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $0.00B indicates a micro-cap company with limited liquidity.
  • Free Cash Flow of $-0.00B reflects negative cash generation, requiring potential external funding.
  • Beta of -1.67 suggests an inverse correlation with the market, potentially offering downside protection during market downturns.
  • Focus on integrated software solutions for healthcare and education sectors positions the company in growing markets.
  • Subsidiary of Meridian Holdings, Inc., providing a degree of corporate structure and potential access to resources.

Güçlü Yönler

  • Specialized software solutions for niche markets.
  • Integrated platform approach.
  • Expertise in RFID technology.
  • Long-standing presence in the market.

Zayıflıklar

  • Limited financial resources.
  • Small market capitalization.
  • Negative free cash flow.
  • Dependence on a limited number of key clients.

Katalizörler

  • Upcoming: Potential new product launches in the telehealth sector by Q4 2026.
  • Ongoing: Increasing adoption of e-learning solutions in educational institutions.
  • Ongoing: Strategic partnerships with healthcare providers to integrate InterCare Clinical Explorer.

Riskler

  • Potential: Competition from larger, more established players with greater resources.
  • Potential: Rapid technological changes rendering existing software obsolete.
  • Ongoing: Regulatory changes in the healthcare and education sectors impacting product compliance.
  • Ongoing: Economic downturns affecting client budgets and software spending.

Büyüme Fırsatları

  • Expansion of e-Learning Integrated Technology Enterprise Systems: The global e-learning market is projected to reach $325 billion by 2025. InterCare DX, Inc. can capitalize on this growth by expanding its e-Learning Integrated Technology Enterprise Systems to new educational institutions and offering enhanced features such as personalized learning paths and AI-powered tutoring. The timeline for this expansion is immediate, focusing on securing partnerships with universities and colleges.
  • Adoption of InterCare Clinical Explorer in Healthcare Enterprises: The healthcare IT market is expected to reach $390 billion by 2024. InterCare DX, Inc. can drive adoption of its InterCare Clinical Explorer by targeting small to medium-sized healthcare providers seeking integrated solutions for managing patient data, streamlining workflows, and improving clinical outcomes. The timeline for this adoption is within the next 1-2 years, focusing on demonstrating the software's ROI and ease of implementation.
  • Integration of RFID Technology in Healthcare Applications: The RFID market in healthcare is projected to reach $5 billion by 2027. InterCare DX, Inc. can leverage its expertise in RFID technology to develop innovative applications for tracking medical equipment, managing inventory, and improving patient safety. The timeline for this integration is within the next 2-3 years, focusing on developing pilot programs with hospitals and clinics.
  • Development of Telehealth Solutions for Remote Patient Monitoring: The telehealth market is expected to reach $55 billion by 2025. InterCare DX, Inc. can develop telehealth solutions that enable remote patient monitoring, virtual consultations, and chronic disease management. This growth opportunity can be realized within the next 1-2 years by focusing on partnerships with telehealth providers and developing user-friendly interfaces.
  • Strategic Partnerships with Healthcare and Education Providers: Forming strategic partnerships with healthcare and education providers can provide InterCare DX, Inc. with access to new markets, customers, and resources. These partnerships can involve joint product development, co-marketing initiatives, and cross-selling opportunities. The timeline for establishing these partnerships is ongoing, focusing on identifying synergistic relationships and negotiating mutually beneficial agreements.

Fırsatlar

  • Expansion into new geographic markets.
  • Development of new software applications.
  • Strategic partnerships with healthcare and education providers.
  • Increased adoption of telehealth and remote patient monitoring.

Tehditler

  • Competition from larger, more established players.
  • Rapid technological changes.
  • Regulatory changes in the healthcare and education sectors.
  • Economic downturns.

Rekabet Avantajları

  • Proprietary software algorithms for relaxation training and stress management.
  • Integrated platform approach offering a comprehensive suite of solutions.
  • Expertise in RFID technology for healthcare applications.
  • Long-standing relationships with key clients in the education and healthcare sectors.

ICCO Hakkında

InterCare DX, Inc., founded in 1991 and based in Hawthorne, California, operates as a biomedical and software products development and services company. Originally known as InterCare Diagnostics, the company creates, publishes, and markets software products embedded with sound, text, and video for relaxation training and stress management. InterCare DX, Inc. also develops integrated Internet-ready and RFID-enabled applications targeting education, hospitality, the legal system, human capital, and the healthcare industry. Its product suite includes e-Learning Integrated Technology Enterprise Systems designed for managing various aspects of education, such as tuition, boarding, lodging, vendor portals, customer relationship management, enterprise budgeting, and financial management. Additionally, the company offers InterCare Clinical Explorer, a software application aimed at integrating virtually all aspects of a healthcare enterprise, and InterCare Vascular Diagnostic Center, a tool for measuring vascular health in patients before the onset of symptoms. InterCare DX, Inc. is a subsidiary of Meridian Holdings, Inc., indicating a structured corporate relationship. The company's focus on integrated software solutions positions it within the evolving landscape of health information services, aiming to streamline operations and enhance patient care through technological innovation.

Ne Yaparlar

  • Develops software products for relaxation training and stress management.
  • Creates integrated Internet-ready and RFID-enabled applications.
  • Offers e-Learning Integrated Technology Enterprise Systems for educational institutions.
  • Provides InterCare Clinical Explorer for healthcare enterprise integration.
  • Offers InterCare Vascular Diagnostic Center for measuring vascular health.
  • Targets diverse sectors including education, hospitality, legal, human capital, and healthcare.

İş Modeli

  • Software licensing and subscription fees for e-Learning Integrated Technology Enterprise Systems.
  • Sales and implementation services for InterCare Clinical Explorer.
  • Custom software development and integration services for healthcare and education clients.

Sektör Bağlamı

InterCare DX, Inc. operates within the health information services industry, a sector experiencing growth driven by the increasing adoption of digital health solutions. The market is characterized by a mix of established players and emerging companies offering specialized software and services. Key trends include the integration of AI and machine learning, the rise of telehealth, and the growing importance of data security and interoperability. InterCare DX, Inc.'s focus on integrated software solutions aligns with these trends, but the company faces competition from larger, more established players with greater resources and broader product portfolios. The company's success will depend on its ability to differentiate its offerings and effectively target niche markets within the healthcare and education sectors.

Kilit Müşteriler

  • Educational institutions (universities, colleges, schools).
  • Healthcare providers (hospitals, clinics, diagnostic centers).
  • Businesses in the hospitality and legal sectors.
  • Human capital management firms.
AI Güveni: 64% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

InterCare DX, Inc. (ICCO) hisse senedi fiyatı: Price data unavailable

Son Haberler

ICCO için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

ICCO için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

ICCO için Wall Street fiyat hedefi analizi.

MoonshotScore

47/100

Bu puan ne anlama geliyor?

MoonshotScore, ICCO'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

ICCO OTC Piyasa Bilgileri

ICCO, OTC Markets'in OTC Other piyasa katmanında işlem görmektedir.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown

ICCO Healthcare Hisse Senedi SSS

ICCO için değerlendirilmesi gereken temel faktörler nelerdir?

InterCare DX, Inc. (ICCO) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Temel güçlü yan: Specialized software solutions for niche markets.. İzlenmesi gereken birincil risk: Potential: Competition from larger, more established players with greater resources.. Bu bir finansal tavsiye değildir.

ICCO MoonshotScore'u nedir?

ICCO şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

ICCO verileri ne sıklıkla güncellenir?

ICCO fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler ICCO hakkında ne diyor?

ICCO için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

ICCO'a yatırım yapmanın riskleri nelerdir?

ICCO için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Competition from larger, more established players with greater resources.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

ICCO'ın P/E oranı nedir?

ICCO için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için ICCO'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

ICCO aşırı değerli mi, yoksa düşük değerli mi?

InterCare DX, Inc. (ICCO)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

ICCO'ın temettü verimi nedir?

InterCare DX, Inc. (ICCO) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited financial data available.
  • AI analysis pending for ICCO.
Veri Kaynakları

Popüler Hisseler